Kenneth Manzo, CEO Manzo Pharmaceuticals, Visited the Probiotic Manufacturing Plant and Was Impressed with the Manufacturer, and Production Has Commenced
CEO of Manzo Pharmaceuticals (OTCPink:MNZO) and creator of patented Lacto-Freedom probiotic, Kenneth Manzo, recently visited their manufacturer's GMP and FDA approved probiotic plant in the USA and expressed his great satisfaction with the manufacturer and their professionalism.
View full press release